Xtant Medical Holdings Inc Market Cap ($67.23 Million)
Market Cap & Net Worth: Xtant Medical Holdings Inc (XTNT)
Xtant Medical Holdings Inc market cap. Xtant Medical Holdings Inc (NYSE MKT:XTNT) has a market capitalization of $67.23 Million ($67.23 Million) as of November 1, 2026. Listed on the NYSE MKT stock exchange, this USA-based company holds position #20574 globally and #4675 in its home market, demonstrating a 2.13% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Xtant Medical Holdings Inc's stock price $0.48 by its total outstanding shares 140068260 (140.07 Million). Also see Xtant Medical Holdings Inc (XTNT) cash conversion ratio for how efficiently the company converts equity into cash flow.
Xtant Medical Holdings Inc Market Cap History (2015–2026)
Xtant Medical Holdings Inc market cap history from 2015 to 2026. Data shows change from $4.71 Billion to $67.23 Million (-34.15% CAGR). Check today's stock price for Xtant Medical Holdings Inc for real-time trading data and today's change.
Xtant Medical Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Xtant Medical Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Xtant Medical Holdings Inc growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.82x
Xtant Medical Holdings Inc's market cap is 0.82 times its annual revenue
Latest Price to Earnings (P/E) Ratio
21.97x
Xtant Medical Holdings Inc's market cap is 21.97 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $924.45 Million | $90.00 Million | -$19.49 Million | 10.27x | N/A |
| 2017 | $962.27 Million | $82.61 Million | -$52.41 Million | 11.65x | N/A |
| 2018 | $225.51 Million | $72.20 Million | -$70.10 Million | 3.12x | N/A |
| 2019 | $224.11 Million | $64.68 Million | -$8.22 Million | 3.46x | N/A |
| 2020 | $167.54 Million | $53.34 Million | -$7.02 Million | 3.14x | N/A |
| 2021 | $78.44 Million | $55.26 Million | -$4.85 Million | 1.42x | N/A |
| 2022 | $92.45 Million | $57.97 Million | -$8.48 Million | 1.59x | N/A |
| 2023 | $158.28 Million | $91.30 Million | $660.00K | 1.73x | 239.81x |
| 2024 | $62.05 Million | $117.27 Million | -$16.45 Million | 0.53x | N/A |
| 2025 | $109.25 Million | $133.93 Million | $4.97 Million | 0.82x | 21.97x |
Competitor Companies of XTNT by Market Capitalization
Companies near Xtant Medical Holdings Inc in the global market cap rankings as of November 1, 2026. Also see XTNT total assets for a full breakdown of the balance sheet.
Key companies related to Xtant Medical Holdings Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $184.67 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #215 globally with a market cap of $111.95 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $184.67 Billion | $106.20 |
| #215 | Stryker Corporation | NYSE:SYK | $111.95 Billion | $291.86 |
| #225 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $96.54 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Xtant Medical Holdings Inc (2015–2026)
Market capitalization of Xtant Medical Holdings Inc from 2015 to today. Between 2015 and today, Xtant Medical Holdings Inc's market cap moved from $4.71 Billion to $ 67.23 Million, with a yearly change of -34.15%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $67.23 Million | -38.46% |
| 2025 | $109.25 Million | +76.07% |
| 2024 | $62.05 Million | -60.80% |
| 2023 | $158.28 Million | +71.21% |
| 2022 | $92.45 Million | +17.86% |
| 2021 | $78.44 Million | -53.18% |
| 2020 | $167.54 Million | -25.24% |
| 2019 | $224.11 Million | -0.62% |
| 2018 | $225.51 Million | -76.56% |
| 2017 | $962.27 Million | +4.09% |
| 2016 | $924.45 Million | -80.36% |
| 2015 | $4.71 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Xtant Medical Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $67.23 Million USD |
| MoneyControl | $67.23 Million USD |
| MarketWatch | $67.23 Million USD |
| marketcap.company | $67.23 Million USD |
| Reuters | $67.23 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Xtant Medical Holdings Inc
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validate… Read more